Prevalence and implications of type D personality in patients with alopecia areata: A marker of quality-of-life impairment and mood status disturbances, a comparative study.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
22
07
2022
accepted:
08
11
2022
medline:
17
4
2023
pubmed:
17
11
2022
entrez:
16
11
2022
Statut:
ppublish
Résumé
Distressed personality (or Type D personality, TDp) is a personality trait that has been associated with poor quality of life in patients suffering from a variety of skin diseases such as psoriasis or urticaria. To date the potential association between Alopecia areata (AA) and TDp has not been studied. The aim of this study was to compare the prevalence of TDp between patients with AA and controls, and to analyse the impact of TDp on patients with AA regarding mood status disturbances, quality of life and sexuality. Cross-sectional study includes patients suffering from mild-to-severe AA and sex- and age-matched healthy controls. Socio-demographic and clinical variables, quality of life, sexual disfunction, anxiety, depression and TDp were collected using validated questionnaires. A total of 120 participants (60 patients and 60 controls) were included. Patients with AA showed higher prevalence of TDp than controls (35% vs. 15% p = 0.01), as well as higher rates of anxiety, depression and sexual dysfunction (p < 0.05). TDp was found to be linked to disease severity (p = 0.04), anxiety and depression scores (p < 0.001) and worse quality of life (p = 0.001). No relationship was found between TDp and sexual dysfunction. Type D personality prevalence is higher in patients with AA than in controls. It is associated with higher rates of anxiety, depression and worse quality of life. Screening for this type of personality could be useful to detect patients who could benefit from additional psychological support as a complement to their medical treatment.
Substances chimiques
DNA-Binding Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1064-1070Informations de copyright
© 2022 European Academy of Dermatology and Venereology.
Références
Dainichi T, Kabashima K. Alopecia areata: what's new in epidemiology, pathogenesis, diagnosis, and therapeutic options? J Dermatol Sci. 2017;86(1):3-12.
Simakou T, Butcher JP, Reid S, Henriquez FL. Alopecia areata: a multifactorial autoimmune condition. J Autoimmun. 2019;98:74-85.
Sánchez-Díaz M, Montero-Vilchez T, Bueno-Rodriguez A, Molina-Leyva A, Arias-Santiago S. Alopecia areata and dexamethasone mini-pulse therapy, a prospective cohort: real world evidence and factors related to successful response. J Clin Med. 2022;11(6):1694.
Phan K, Ramachandran V, Sebaratnam DF. Methotrexate for alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(1):120-127.e2.
Sanchez-Diaz M, Diaz-Calvillo P, Rodriguez-Pozo J-A, Tercedor-Sánchez J, Cantudo-Cuenca M-R, Molina-Leyva A, et al. Tofacitinib for treatment of alopecia areata: real-world evidence and factors associated with therapeutic response. Acta Derm Venereol. 2022;102:adv00736.
Rencz F, Gulácsi L, Péntek M, Wikonkál N, Baji P, Brodszky V. Alopecia areata and health-related quality of life: a systematic review and meta-analysis. Br J Dermatol. 2016;175(3):561-71.
Ruiz-Doblado S, Carrizosa A, García-Hernández MJ. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol. 2003;42(6):434-7.
Sellami R, Masmoudi J, Ouali U, Mnif L, Amouri M, Turki H, et al. The relationship between alopecia areata and alexithymia, anxiety and depression: a case-control study. Indian J Dermatol. 2014;59(4):421.
Mols F, Denollet J. Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems. Health Qual Life Outcomes. 2010;8:9.
Beutel ME, Wiltink J, Till Y, Wild PS, Münzel T, Ojeda FM, et al. Type D personality as a cardiovascular risk marker in the general population: results from the Gutenberg health study. Psychother Psychosom. 2012;81(2):108-17.
Kim SR, Nho J-H, Kim HY, Ko E, Jung S, Kim I-Y, et al. Type-D personality and quality of life in patients with primary brain tumours. Eur J Cancer Care (Engl). 2021;30(2):e13371.
Akram U, McCarty K, Akram A, Gardani M, Tan A, Villarreal D, et al. The relationship between type D personality and insomnia. Sleep Heal. 2018;4(4):360-3.
Gębska M, Dalewski B, Pałka Ł, Kołodziej Ł, Sobolewska E. The importance of type D personality in the development of temporomandibular disorders (TMDs) and depression in students during the COVID-19 pandemic. Brain Sci. 2021;12(1):28.
Chilicka K, Rogowska AM, Szyguła R, Adamczyk E. Association between satisfaction with life and personality types a and D in young women with acne vulgaris. Int J Environ Res Public Health. 2020;17(22):8524.
Molina-Leyva A, Caparros-delMoral I, Ruiz-Carrascosa JC, Naranjo-Sintes R, Jimenez-Moleon JJ. Elevated prevalence of type D (distressed) personality in moderate to severe psoriasis is associated with mood status and quality of life impairment: a comparative pilot study. J Eur Acad Dermatol Venereol. 2015;29(9):1710-7.
Sánchez-Díaz M, Salazar-Nievas M-C, Molina-Leyva A, Arias-Santiago S. Type D personality is associated with poorer quality of life in patients with chronic spontaneous urticaria: a cross-sectional study. Acta Derm Venereol. 2022;102:adv00734. (SE-Articles). https://medicaljournalssweden.se/actadv/article/view/676
Mols F, Holterhues C, Nijsten T, van de Poll-Franse LV. Personality is associated with health status and impact of cancer among melanoma survivors. Eur J Cancer. 2010;46(3):573-80.
Olsen EA, Canfield D. SALT II: a new take on the severity of alopecia tool (SALT) for determining percentage scalp hair loss. J Am Acad Dermatol. 2016;75:1268-70.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) -a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-6.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70.
Alcaraz S, Hidalgo MD, Godoy C, Fernandez E. Spanish validation of the type D personality scale (ds14). Behav Psychol Conduct. 2018;26:195+.
Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med. 2005;67(1):89-97.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-26.
Isidori AM, Pozza C, Esposito K, Giugliano D, Morano S, Vignozzi L, et al. Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction. J Sex Med. 2010;7(3):1139-46.
Barone S, Bacon SL, Campbell TS, Labrecque M, Ditto B, Lavoie KL. The association between anxiety sensitivity and atopy in adult asthmatics. J Behav Med. 2008;31(4):331-9.
Manoj MT, Joseph KA, Vijayaraghavan G. Type D personality and myocardial infarction: a case-control study. Indian J Psychol Med. 2020;42(6):555-9.
Okhovat J-P, Marks DH, Manatis-Lornell A, Hagigeorges D, Locascio JJ, Senna MM. Association between alopecia areata, anxiety, and depression: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;S0190-9622(19):30890-4.
Ilchmann-Diounou H, Menard S. Psychological stress, intestinal barrier dysfunctions, and autoimmune disorders: an overview. Front Immunol. 2020;11:1823.
Basińska MA, Woźniewicz A. The relation between type D personality and the clinical condition of patients suffering from psoriasis. Postepy Dermatol Alergol. 2013;30(6):381-7.